Fig. 3From: Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumabRFS by clustering; clustered by baseline cytokine levels: Panel a RFS in cluster 1 versus cluster 2, where patients are clustered by cytokine expression profile at baseline. Panel b RFS in cluster 1 versus cluster 2, where patients are clustered by cytokine expression profile at week 6Back to article page